|
March 26, 2008
FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) mark...
Read More...
March 19, 2008
FluoroPharma Inc., a company developing breakthrough cardiovascular molecular imaging agents for the Positron Emission Tomogr...
Read More...
March 3, 2008
FluoroPharma Inc., a company developing breakthrough cardiovascular molecular imaging agents for the Positron Emission Tomogr...
Read More... |
Shaping the Future of Molecular PET Imaging
FluoroPharma is developing breakthrough molecular imaging agents for positron emission tomography (PET) and fluorescence imaging that will fulfill critical unmet medical needs. The company’s agents will give clinicians important tools for the detection and assessment of pathology before clinical manifestations of disease.
|